Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Allodynic Therapeutics, Inc
Allodynic Therapeutics, Inc
Industry · 7 registered clinical trials.
Status
Trial
Phase
Started
Withdrawn
Single-Site Study of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Phase 2 Randomized Trial
Migraine
Phase 2
2025-01-31
Completed
The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination
Migraine With or Without Aura
Phase 2
2017-08-25
Completed
Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)
Chronic Low Back Pain, Lumbar Radiculopathy
Phase 2
2017-08-15
Completed
Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Naus
Migraine With and Without Aura
Phase 2 / Phase 3
2017-06-27
Completed
An Acute Migraine Factorial Study
Migraine With or Without Aura
Phase 2
2017-02-18
Completed
Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine
Migraine With or Without Aura
Phase 2
2017-02-18
Withdrawn
Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain
Atypical Facial Pain, Persistent Idiopathic Facial Pain, Atypical Trigeminal Neuralgia
Phase 2 / Phase 3
2014-03-01